JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.3B |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.64B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.55B |
| 4 |
iShares MBS ETF
MBB
|
+$1.29B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
CVS Health
CVS
|
+$676M |
| 3 |
Johnson & Johnson
JNJ
|
+$669M |
| 4 |
Mondelez International
MDLZ
|
+$593M |
| 5 |
UnitedHealth
UNH
|
+$572M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.25% |
| 2 | Technology | 12.49% |
| 3 | Financials | 12.17% |
| 4 | Healthcare | 9.9% |
| 5 | Consumer Discretionary | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5351
ZW Data Action Technologies
CNET
$5.87M
| $9K | ﹤0.01% |
230
-5
| -2% | -$169 |
2018 Q4
1 quarter
|
|
5352
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
$7.89B
| $9K | ﹤0.01% |
+94
| New | +$9.42K |
2019 Q1
0 quarters
|
|
5353
ProShares Ultra MidCap400
MVV
$144M
| $9K | ﹤0.01% |
+218
| New | +$8.12K |
2019 Q1
0 quarters
|
|
5354
ProShares Short Russell2000
RWM
$155M
| $9K | ﹤0.01% |
+225
| New | +$9.38K |
2019 Q1
0 quarters
|
|
|
RVLP
5355
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $9K | ﹤0.01% |
2,379
-557
| -19% | -$4.1K |
2018 Q4
1 quarter
|
|
|
DVD
5356
DELISTED
Dover Motorsports
DVD
| $9K | ﹤0.01% |
4,576
-407
| -8% | -$819 |
2016 Q4
9 quarters
|
|
|
MCEP
5357
DELISTED
Mid-Con Energy Partners, LP
MCEP
| $9K | ﹤0.01% |
522
| – | – |
2015 Q3
14 quarters
|
|
|
SNNA
5358
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
| $9K | ﹤0.01% |
3,939
-15,143
| -79% | -$41K |
2017 Q3
6 quarters
|
|
5359
BlackRock Enhanced Global Dividend Trust
BOE
$650M
| $8K | ﹤0.01% |
750
| – | – |
2018 Q4
1 quarter
|
|
|
EB
5360
DELISTED
Eventbrite
EB
| $8K | ﹤0.01% |
+443
| New | +$12.5K |
2019 Q1
0 quarters
|
|
5361
FVCBankcorp
FVCB
$321M
| $8K | ﹤0.01% |
611
+18
| +3% | +$252 |
2018 Q4
1 quarter
|
|
5362
Invesco CurrencyShares Canadian Dollar Trust
FXC
$65.1M
| $8K | ﹤0.01% |
110
+100
| +1,000% | +$7.42K |
2017 Q1
8 quarters
|
|
|
IFN
5363
Aberdeen India Fund
IFN
$454M
| $8K | ﹤0.01% |
371
| – | – |
2018 Q4
1 quarter
|
|
5364
iShares Morningstar Small-Cap Growth ETF
ISCG
$971M
| $8K | ﹤0.01% |
+246
| New | +$7.82K |
2019 Q1
0 quarters
|
|
|
CPTL
5365
Global X Morningstar Capital Allocation Leaders ETF
CPTL
$114M
| $8K | ﹤0.01% |
400
| – | – |
2017 Q3
6 quarters
|
|
5366
Limbach Holdings
LMB
$586M
| $8K | ﹤0.01% |
1,000
| – | – |
2018 Q4
1 quarter
|
|
5367
NLI Holdings
NL
$341M
| $8K | ﹤0.01% |
2,134
-906
| -30% | -$3.7K |
2016 Q4
9 quarters
|
|
|
IMVP
5368
Invesco India ETF
IMVP
$94.1M
| $8K | ﹤0.01% |
334
| – | – |
2013 Q2
23 quarters
|
|
5369
Pearson
PSO
$9.69B
| $8K | ﹤0.01% |
688
-50,000
| -99% | -$583K |
2014 Q3
18 quarters
|
|
5370
iShares Global Consumer Discretionary ETF
RXI
$297M
| $8K | ﹤0.01% |
75
| – | – |
2018 Q1
4 quarters
|
|
5371
iShares MSCI Japan Small-Cap ETF
SCJ
$264M
| $8K | ﹤0.01% |
+119
| New | +$8.24K |
2019 Q1
0 quarters
|
|
|
LUB
5372
DELISTED
Luby's Inc.
LUB
| $8K | ﹤0.01% |
5,787
+648
| +13% | +$991 |
2016 Q4
9 quarters
|
|
|
QTRH
5373
DELISTED
Quarterhill Inc. Common Shares
QTRH
| $8K | ﹤0.01% |
7,155
-170,300
| -96% | -$176K |
2017 Q2
7 quarters
|
|
|
AVDL
5374
DELISTED
Avadel Pharmaceuticals
AVDL
| $7K | ﹤0.01% |
4,700
| – | – |
2018 Q2
3 quarters
|
|
|
GENZ
5375
VanEck Digital Native Economy ETF
GENZ
$16.4M
| $7K | ﹤0.01% |
194
| – | – |
2017 Q1
8 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2019 Portfolio in Review
As of Q1 2019, JP Morgan Chase held 6,314 positions worth $490B, up 13% from $432B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2019 filing shows 537 new, 2,080 increased, 2,670 reduced and 537 closed positions. Its largest new stake was Lyft: 2,510,596 shares worth $197M. The largest sale was Apple, an estimated $693M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q1 2019 buy was Lyft: 2,510,596 shares worth $197M.
- JP Morgan Chase added most to Vanguard Total International Bond ETF in Q1 2019, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q1 2019 reduction was Apple, cutting an estimated $693M.
- JP Morgan Chase fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $164M.
- JP Morgan Chase's ten largest holdings make up 16% of its $490B portfolio in Q1 2019.
- JP Morgan Chase opened 537 new positions and closed 537 in Q1 2019.
- JP Morgan Chase's portfolio value rose 13% quarter-over-quarter to $490B.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.